Skip to content
OpenCapital
Get started

Incyte INCY United States — Total revenues

Similar metrics at other companies

Ardelyx logo
ARDXUnited States — Total revenues
$94.45M+18.4%
Schrodinger logo
SDGRUnited States — Total revenues
$31.41M+5.9%
CareDx logo
CDNAUnited States — Total Revenue
$113.65M+42.3%
Enovix Corporation logo
ENVXUnited States — Total revenues
$530K+138%
Acacia Research logo
ACTGUnited States — Total revenues
$37.65M-65.4%
Azenta logo
AZTAUnited States — Total Revenue
$83.02M-7.7%

Other financials

Income statement

See full
Revenue$1.3B+20.9%
Gross profit$1.2B+19.2%
Operating income$301.1M+46.8%
Net income$303.3M+91.7%
EPS (diluted)$1.47+83.7%

Balance sheet

See full
Cash & equivalents$3.5B+78.2%
Total debt$39.4M-8.6%
Total equity$5.6B+53.3%
Total assets$7.3B+27.7%

Cash flow

See full
Operating cash flow$369.4M+38.8%
CapEx$1.6M-43.5%
Free cash flow$367.7M+39.7%

Valuation

See full
Market cap$22.82B+74.2%
Enterprise value$19.4B+73.4%
P/E15.9×+0.9×
P/S4.3×+1.4×

Profitability

See full
Gross margin92.5%-0.2pp
Operating margin30%+26.1pp
Net margin26.7%+26.2pp
FCF margin28.2%+19.7pp

Returns & leverage

See full
Return on equity30.8%+30.4pp
Debt / equity0×0.0×
Current ratio3.7×+1.6×

Where this comes from

Reported directly by Incyte in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Incyte’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Incyte's united states — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Incyte's united states — total revenues?
Incyte (INCY) reported united states — total revenues of $1.17B in Q1 2026.
How has Incyte's united states — total revenues changed year-over-year?
Incyte's united states — total revenues increased by 19.3% year-over-year, from $981.56M to $1.17B.
What is the long-term trend for Incyte's united states — total revenues?
Over 4 years (2021 to 2025), Incyte's united states — total revenues has grown at a 13.4% compound annual growth rate (CAGR), from $2.9B to $4.8B.
What does united states — total revenues mean?
This metric represents the total gross revenue generated from all commercial activities within the United States geographic segment. It encompasses sales of pharmaceutical products, licensing fees, and royalty income derived from domestic operations. This figure serves as a primary indicator of the company's market penetration and commercial success within its largest operating region.